US2022290123A1PendingUtilityA1
Method for purifying rna
Est. expiryNov 28, 2036(~10.3 yrs left)· nominal 20-yr term from priority
C12N 15/101C12N 15/1006
66
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention relates to methods for purifying RNA by chromatography under high salt conditions, e.g. by hydrophobic interaction chromatography.
Claims
exact text as granted — not AI-modified1 . Method for purifying RNA, comprising the steps of:
a) applying a sample containing RNA in an equilibration buffer having a high salt concentration to a support material capable of binding the RNA under high salt conditions, wherein the support comprises hydroxyl or sulfate groups; b) optionally washing the support material with a washing buffer having a high salt concentration; and c) eluting the nucleic acid from the support material with an elution solution.
2 . Method according to claim 1 , wherein the RNA is obtained by RNA in vitro transcription.
3 . Method according to claim 1 or 2 , wherein the equilibration buffer and/or the washing buffer has a salt concentration of 50 mM to 5M.
4 . Method according to any one of the preceding claims, wherein the equilibration buffer and/or the washing buffer comprises sodium chloride or ammonium sulfate.
5 . Method according to any one of the preceding claims, wherein the equilibration buffer and/or the washing buffer comprises 2 M NaCl.
6 . Method according to any one of the preceding claims, wherein the equilibration buffer and/or the washing buffer comprises 20 mM HEPES-NaOH, pH 7.0, 2 M NaCl.
7 . Method according to any one of the preceding claims, wherein the equilibration buffer and the washing buffer have the same composition and the same pH.
8 . Method according to any one of the preceding claims, wherein the support material is a monolithic support material.
9 . Method according to any one of the preceding claims, wherein the support material is a methacrylate polymer.
10 . Method according to any one of the preceding claims, wherein the RNA is eluted by gradually decreasing the salt concentration.
11 . Method according to any one of the preceding claims, wherein the elution solution does not contain a salt.
12 . Method according to any one of the preceding claims, wherein the elution solution comprises 20 mM HEPES-NaOH, pH 7.0.
13 . Method for purifying in vitro transcribed RNA, comprising the steps of:
a) transcribing RNA from a template DNA in vitro; b) applying a sample containing the in vitro transcribed RNA in an equilibration buffer having a high salt concentration to a support material capable of binding the RNA under high salt conditions, wherein the support material comprises hydroxyl or sulfate groups; c) washing the support material with a washing buffer having a high salt concentration; and d) eluting the RNA from the support material with an elution solution.
14 . Method according to claim 13 , further comprising a step a1) of degrading the template DNA.
15 . Method according to claim 14 , wherein the template DNA is degraded by treatment with DNase.
16 . Method according to any one of claims 13 to 15 , further comprising a step a2) of subjecting the in vitro transcribed RNA to an RP-HPLC step.
17 . Method according to any one of claims 13 to 16 , further comprising a step e) of preparing a pharmaceutical composition comprising said RNA.
18 . Method according to any one of claims 13 to 17 , wherein the equilibration buffer and/or the washing buffer has a salt concentration of 50 mM to 5M.
19 . Method according to any one of claims 13 to 18 , wherein the equilibration buffer and/or the washing buffer comprises sodium chloride or ammonium sulfate.
20 . Method according to any one of claims 13 to 19 , wherein the equilibration buffer and/or the washing buffer comprises 2 M NaCl.
21 . Method according to any one of claims 13 to 20 , wherein the equilibration buffer and/or the washing buffer comprises 20 mM HEPES-NaOH, pH 7.0, 2 M NaCl.
22 . Method according to any one of claims 13 to 21 , wherein the equilibration buffer and the washing buffer have the same composition and the same pH.
23 . Method according to any one of claims 13 to 22 , wherein the support material is a monolithic support material.
24 . Method according to any one of claims 13 to 23 , wherein the support material is a methacrylate polymer.
25 . Method according to any one of claims 13 to 24 , wherein the RNA is eluted by gradually decreasing the salt concentration.
26 . Method according to any one of claims 13 to 25 , wherein the elution solution does not contain a salt.
27 . Method according to any one of claims 13 to 26 , wherein the elution buffer comprises 20 mM HEPES-NaOH, pH 7.0.
28 . Use of hydrophobic interaction chromatography for the purification of RNA obtained by RNA in vitro transcription.Join the waitlist — get patent alerts
Track US2022290123A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.